Table Of Contents

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

 1.1.1 Why This Market Is Gaining Strategic Attention

     1.1.2 Business Decisions This Report Supports

 1.2 Scope

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Disease Indication

  2.3.2 Market Size By Treatment

  2.3.3 Market Size By End-User

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Active Pharmaceutical Ingredients (APIs), Antidepressant Raw Materials, Excipients, Digital Health Technology Providers & Diagnostic Assessment Tool Suppliers

3.4.2 Pharmaceutical Manufacturers, Digital Mental Health Platform Developers, Drug Formulation, Clinical Development, Software Development & Quality Assurance Providers

3.4.3 Pharmaceutical Distributors, Telehealth Service Networks, Hospital Pharmacy Systems, Digital Healthcare Platforms & Healthcare Logistics Providers

3.4.4 Hospitals, Obstetrics & Gynecology Clinics, Mental Health Centers, Telehealth Platforms, Healthcare Professionals, Mothers, Caregivers & Patients

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

 4.1 Market Adoption & Patient Care Trends

4.1.1 Maternal Mental Health Treatment Adoption by Disease Indication

4.1.2 Psychotherapy vs. Pharmacotherapy Utilisation Analysis

4.1.3 Telehealth Adoption for Maternal Mental Health Services

4.1.4 Postpartum Depression Diagnosis & Care Trends

4.1.5 Patient Engagement & Treatment Adherence Analysis

4.2 Clinical Innovation & Digital Health Insights

4.2.1 Advances in Digital Mental Health Platforms

4.2.2 Innovation in Maternal Mental Health Therapeutics

4.2.3 AI-Enabled Screening & Risk Assessment Trends

4.2.4 Remote Monitoring & Virtual Care Developments

4.2.5 Clinical Trial & Regulatory Approval Landscape

4.3 Commercial & Industry Intelligence

4.3.1 Treatment Cost & Reimbursement Trends

4.3.2 Competitive Benchmarking of Leading Market Participants

4.3.3 Strategic Partnerships, Investments & Acquisition Activity

4.3.4 Healthcare Provider Network & Referral Trends

4.3.5 Public Health Funding & Maternal Wellness Initiatives

4.4 Future Outlook & Emerging Opportunities

4.4.1 Expansion of Digital Maternal Mental Healthcare Services

4.4.2 Growing Integration of Personalised Mental Health Solutions

4.4.3 Opportunities in Preventive Maternal Mental Healthcare

4.4.4 Future Roadmap for Integrated Maternal Mental Health Management

5. Maternal Mental Health Market Segmental Analysis & Forecast, By Disease Indication, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Pregnancy and Postpartum General Anxiety

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Postpartum Depression

 5.4 Dysthymia

 5.5 Psychosis

6. Maternal Mental Health Market Segmental Analysis & Forecast, By Treatment, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Interpersonal Psychotherapy

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Antidepressants Pharmacotherapy

7. Maternal Mental Health Market Segmental Analysis & Forecast, By End-User, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Hospitals and Clinics

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Telehealth Digital Platforms

8. Maternal Mental Health Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

8.1 Introduction

8.2 North America

 8.2.1 Key Trends

 8.2.2 Maternal Mental Health Market Size & Forecast, By Disease Indication, 2022–2035

 8.2.3 Maternal Mental Health Market Size & Forecast, By Treatment, 2022–2035

 8.2.4 Maternal Mental Health Market Size & Forecast, By End-User, 2022–2035

 8.2.5 Maternal Mental Health Market Size & Forecast, By Country, 2022–2035

  8.2.5.1 USA

  8.2.5.2 Canada

8.3 Europe

 8.3.1 Key Trends

 8.3.2 Maternal Mental Health Market Size & Forecast, By Disease Indication, 2022–2035

 8.3.3 Maternal Mental Health Market Size & Forecast, By Treatment, 2022–2035

 8.3.4 Maternal Mental Health Market Size & Forecast, By End-User, 2022–2035

 8.3.5 Maternal Mental Health Market Size & Forecast, By Country, 2022–2035

  8.3.5.1 Germany

  8.3.5.2 UK

  8.3.5.3 France

  8.3.5.4 Italy

  8.3.5.5 Spain

  8.3.5.6 Russia

  8.3.5.7 Poland

  8.3.5.8 Rest of Europe

8.4 Asia-Pacific

 8.4.1 Key Trends

 8.4.2 Maternal Mental Health Market Size & Forecast, By Disease Indication, 2022–2035

 8.4.3 Maternal Mental Health Market Size & Forecast, By Treatment, 2022–2035

 8.4.4 Maternal Mental Health Market Size & Forecast, By End-User, 2022–2035

 8.4.5 Maternal Mental Health Market Size & Forecast, By Country, 2022–2035

  8.4.5.1 China

  8.4.5.2 India

  8.4.5.3 Japan

  8.4.5.4 South Korea

  8.4.5.5 Australia

  8.4.5.6 ASEAN Countries

  8.4.5.7 Rest of Asia-Pacific

8.5 Latin America

 8.5.1 Key Trends

 8.5.2 Maternal Mental Health Market Size & Forecast, By Disease Indication, 2022–2035

 8.5.3 Maternal Mental Health Market Size & Forecast, By Treatment, 2022–2035

 8.5.4 Maternal Mental Health Market Size & Forecast, By End-User, 2022–2035

 8.5.5 Maternal Mental Health Market Size & Forecast, By Country, 2022–2035

  8.5.5.1 Brazil

  8.5.5.2 Argentina

  8.5.5.3 Mexico

  8.5.5.4 Colombia

  8.5.5.5 Rest of Latin America

8.6 Middle East & Africa

 8.6.1 Key Trends

 8.6.2 Maternal Mental Health Market Size & Forecast, By Disease Indication, 2022–2035

 8.6.3 Maternal Mental Health Market Size & Forecast, By Treatment, 2022–2035

 8.6.4 Maternal Mental Health Market Size & Forecast, By End-User, 2022–2035

 8.6.5 Maternal Mental Health Market Size & Forecast, By Country, 2022–2035

  8.6.5.1 UAE

  8.6.5.2 Saudi Arabia

  8.6.5.3 Qatar

  8.6.5.4 South Africa

  8.6.5.5 Rest of Middle East & Africa

9. Competitive Landscape

 9.1 Key Players' Positioning

 9.2 Competitive Developments

  9.2.1 Key Strategies Adopted (%), By Key Players, 2025

  9.2.2 Year-Wise Strategies & Development, 2022–2025

  9.2.3 Number Of Strategies Adopted By Key Players, 2025

 9.3 Market Share Analysis, 2025

 9.4 Disease Indication/Service & Treatment Benchmarking

  9.4.1 Disease Indication/Service Specifications & Features By Key Players

  9.4.2 Disease Indication/Service Heatmap By Key Players

  9.4.3 Treatment Heatmap By Key Players

 9.5 Industry Start-Up & Innovation Landscape

9.6 Key Company Profiles

 9.6.1 Maven Clinic

  9.6.1.1 Company Overview & Snapshot

  9.6.1.2 Disease Indication/Service Portfolio

  9.6.1.3 Key Company Financials

  9.6.1.4 SWOT Analysis

 9.6.2 Wildflower Health

9.6.3 Hims & Hers Health, Inc.

9.6.4 Medela LLC

9.6.5 Clue

9.6.6 Postpartum Support International

9.6.7 LunaJoy Health

9.6.8 Brightside Health, Inc.

9.6.9 Viatris Inc.

9.6.10 GSK plc

9.6.11 Alembic Pharmaceuticals Limited

9.6.12 Mallinckrodt plc

9.6.13 Sage Therapeutics, Inc.

9.6.14 Bausch Health Companies Inc.

9.6.15 Magellan Health, Inc.

9.6.16 Pfizer Inc.

9.6.17 Eli Lilly and Company

9.6.18 Lipocine Inc.

9.6.19 Canopie

9.6.20 Seleni Institute

10. Analyst Recommendations

 10.1 SNS Insider Opportunity Map

 10.2 Industry Low-Hanging Fruit Assessment

 10.3 Market Entry & Growth Strategy

 10.4 Analyst Viewpoint & Suggestions On Market Growth

11. Assumptions

12. Disclaimer

13. Appendix

 13.1 List Of Tables

 13.2 List Of Figures